Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
CA |
|
A
|
argenx SE
F:1AE
|
NL |
|
Agnico Eagle Mines Ltd
TSX:AEM
|
CA |
|
Medipharm Labs Corp
TSX:LABS
|
CA |
|
Electro Optic Systems Holdings Ltd
ASX:EOS
|
AU |
|
NetApp Inc
NASDAQ:NTAP
|
US |
|
UNITY Biotechnology Inc
NASDAQ:UBX
|
US |
|
C
|
Concentra Group Holdings Parent Inc
NYSE:CON
|
US |
|
C
|
China Resources Beer Holdings Co Ltd
XMUN:CHK
|
HK |
|
I
|
Interpublic Group of Companies Inc
XMUN:IPG
|
US |
|
Sherwin-Williams Co
NYSE:SHW
|
US |
|
F
|
Fluor Corp
SWB:FLU
|
US |
|
Koninklijke Philips NV
AEX:PHIA
|
NL |
|
S
|
Shanghai Industrial Holdings Ltd
SWB:SGI
|
HK |
|
Black Iron Inc
TSX:BKI
|
CA |
|
Sidus Space Inc
NASDAQ:SIDU
|
US |
|
S
|
SS&C Technologies Holdings Inc
F:WGSA
|
US |
|
I
|
Intact Financial Corp
F:I5U
|
CA |
|
P
|
Pioneer Natural Resources Co
LSE:0KIX
|
US |
|
H
|
Hershey Co
XMUN:HSY
|
US |
|
F
|
Franklin Resources Inc
XMUN:FRK
|
US |
|
Pilbara Minerals Ltd
ASX:PLS
|
AU |
|
H
|
Heriot REIT Ltd
JSE:HET
|
ZA |
Wall St Price Targets
AUPH Price Targets Summary
Aurinia Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for AUPH is 17.34 USD with a low forecast of 15.15 USD and a high forecast of 22.05 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AUPH's stock price target?
Price Target
17.34
USD
According to Wall Street analysts, the average 1-year price target for AUPH is 17.34 USD with a low forecast of 15.15 USD and a high forecast of 22.05 USD.
What is the Revenue forecast for Aurinia Pharmaceuticals Inc?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 8 years is 16%.
What is the Operating Income forecast for Aurinia Pharmaceuticals Inc?
Projected CAGR
24%
The compound annual growth rate for Operating Income over the next 8 years is 24%.
What is the Net Income forecast for Aurinia Pharmaceuticals Inc?
Projected CAGR
6%
The compound annual growth rate for Net Income over the next 8 years is 6%.
